Guilherme Martins Silva

University of North Carolina at Chapel Hill — United States

Computer Science · Physical Sciences

11h-index272citations33works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(15), Cholinesterase and Neurodegenerative Diseases(6), Synthesis and biological activity(4), Pharmacogenetics and Drug Metabolism(3), Metabolomics and Mass Spectrometry Studies(3)

Publications33 total

Mitochondrial control of fuel switching via carnitine biosynthesis
2025Open Access
Mitochondria-derived PEP licenses glycerolipid synthesis via SLC25A35
2025Open Access
Synthesis and antifungal activity of polyalthic acid-1,2,3-triazole-arylsulfonamide derivatives
Tetrahedron Letters·2025
Pharmacokinetics Profiler (PhaKinPro): Model Development, Validation, and Implementation as a Web Tool for Triaging Compounds with Undesired Pharmacokinetics Profiles
UNC Libraries·2025Open Access
Synthesis of Quinic Acid‐Derived Sialylmimetics and Their Effects on <i>T. cruzi</i> and <i>Trans</i> ‐ <i>Sialidase</i>
ChemistrySelect·2025Open Access
Structural analysis and shape-based identification of novel inhibitors targeting the Trypanosoma cruzi proteasome
International Journal of Biological Macromolecules·2024· 1 cited
Pharmacokinetics Profiler (PhaKinPro): Model Development, Validation, and Implementation as a Web Tool for Triaging Compounds with Undesired Pharmacokinetics Profiles
Journal of Medicinal Chemistry·2024· 23 cited
Antiallergic, Antioxidant, Anti-Inflammatory and Immunostimulant Potential of Kefiran Postbiotic: Molecular Docking, Prediction of Pharmacokinetic Properties and Biological Activity
Engineering materials·2024
In Silico Design of Acetylcholinesterase and Glycogen Synthase Kinase-3β Multi-target Inhibitors
Engineering materials·2023
Discovery of Potential GSK-3β Allosteric Modulators for Alzheimer’s Disease
2023· 1 citedOpen Access
Novel Pharmacokinetics Profiler (PhaKinPro): Model Development, Validation, and Implementation as a Web-Tool for Triaging Compounds with Undesired PK Profiles
2023· 3 citedOpen Access
Ligand-based virtual screening, molecular dynamics, and biological evaluation of repurposed drugs as inhibitors of <i>Trypanosoma cruzi</i> proteasome
Journal of Biomolecular Structure and Dynamics·2023· 1 cited
Parasitism of terrestrial gastropods by medically-important nematodes in Brazil
Frontiers in Veterinary Science·2022· 18 citedOpen Access
Pharmacophore-based virtual screening from phytocannabinoids as antagonist r-CB1
Journal of Molecular Modeling·2022· 1 cited
Hierarchical Virtual Screening Based on Rocaglamide Derivatives to Discover New Potential Anti-Skin Cancer Agents
Frontiers in Molecular Biosciences·2022· 16 citedOpen Access
Chromatographic profile, in silico and in vivo study of the pharmacokinetic and toxicological properties of major constituent present in kefir, the kefiran
Toxicology Research·2022· 2 citedOpen Access
Structural Aspects of Organic Compounds as Proteasome Inhibitors Addressed to Several Diseases
Engineering materials·2022· 4 cited
Advances in Computational Techniques for Discovery and Development of Drugs Against Leishmaniasis, a Brief Review
Engineering materials·2022· 1 cited
Lead Optimization in Drug Discovery
Engineering materials·2022· 10 cited
Potential colchicine binding site inhibitors unraveled by virtual screening, molecular dynamics and MM/PBSA
Computers in Biology and Medicine·2021· 24 cited
page 1 of 2Next →

Frequent Co-authors

Carlos Henrique Tomich de Paula da Silva(22), Mariana Pegrucci Barcelos(10), Lorane Izabel da Silva Hage-Melim(10), Leonardo Bruno Federico(8), Suzane Quintana Gomes(8), Isaque Antônio Galindo Francischini(6), Cleydson B. R. Santos(6), Carlton A. Taft(6), Joshua E. Hochuli(4), Eugene Muratov(4), Alexander Tropsha(4), Henrique Barros de Lima(4), Sérgio de Albuquerque(3), Rodrigo Alves Soares Cruz(3), Marielle Rath(3), James Wellnitz(3), Holli‐Joi Martin(3), Cleber C. Melo‐Filho(3), Jon-Michael Beasley(3), Zoe L. Sessions(3)